261 related articles for article (PubMed ID: 10030673)
1. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
6. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
7. Asbestos induces activator protein-1 transactivation in transgenic mice.
Ding M; Dong Z; Chen F; Pack D; Ma WY; Ye J; Shi X; Castranova V; Vallyathan V
Cancer Res; 1999 Apr; 59(8):1884-9. PubMed ID: 10213496
[TBL] [Abstract][Full Text] [Related]
8. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
Liu G; Bode A; Ma WY; Sang S; Ho CT; Dong Z
Cancer Res; 2001 Aug; 61(15):5749-56. PubMed ID: 11479211
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
10. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
11. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
12. The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells.
Huang C; Ma WY; Dong Z
Oncogene; 1999 May; 18(18):2828-35. PubMed ID: 10362253
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; IƱiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
15. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
Lin S; Li JJ; Fujii M; Hou DX
Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
Wang SY; Feng R; Lu Y; Bowman L; Ding M
J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction.
Nomura M; Yamazaki R; Takaya M; Kikuchi M; Takahashi-Nishioka T; Akiyama K; Akiyama N; Moritani S; Kobayashi S
Anticancer Res; 2007; 27(5A):3187-93. PubMed ID: 17970060
[TBL] [Abstract][Full Text] [Related]
18. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
[TBL] [Abstract][Full Text] [Related]
20. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
Huang C; Ma WY; Young MR; Colburn N; Dong Z
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]